Effects of combined exercise and progesterone treatments on cocaine seeking in male and female rats

被引:0
作者
Natalie E. Zlebnik
Amy T. Saykao
Marilyn E. Carroll
机构
[1] University of Minnesota,Graduate Program in Neuroscience
[2] University of Minnesota,Department of Psychiatry
来源
Psychopharmacology | 2014年 / 231卷
关键词
Exercise; Progesterone; Cocaine; Reinstatement; Relapse; Addiction; Sex differences;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:3787 / 3798
页数:11
相关论文
共 294 条
[1]  
Anker JJ(2010)Sex differences in the effects of allopregnanolone on yohimbine-induced reinstatement of cocaine seeking in rats Drug Alcohol Depend 107 264-267
[2]  
Carroll ME(2011)Females are more vulnerable to drug abuse than males: evidence from preclinical studies and the role of ovarian hormones Curr Top Behav Neurosci 8 73-96
[3]  
Anker JJ(2007)Effects of progesterone on the reinstatement of cocaine-seeking behavior in female rats Exp Clin Psychopharmacol 15 472-480
[4]  
Carroll ME(2012)Effects of progesterone on escalation of intravenous cocaine self-administration in rats selectively bred for high or low saccharin intake Behav Pharmacol 23 205-210
[5]  
Anker JJ(2013)Let’s get physical: a contemporary review of the anxiolytic effects of exercise for anxiety and its disorders Depress Anxiety 30 362-373
[6]  
Larson EB(1990)Estrogen rapidly potentiates amphetamine-induced striatal dopamine release and rotational behavior during microdialysis Neurosci Lett 118 169-171
[7]  
Gliddon LA(1997)Modeling the effects of combined behavioral and pharmacological treatment on cigarette smoking: behavioral–economic analyses Exp Clin Psychopharm 5 334-343
[8]  
Carroll ME(1995)Anxiolytic effect of progesterone is mediated by the neurosteroid allopregnanolone at brain GABAA receptors J Neuroendocrinol 7 171-177
[9]  
Anker JJ(1999)Sex differences in the relationship between activity and weight loss in the rat Behav Neurosci 113 1080-1089
[10]  
Holtz NA(1997)The anxiolytic-like effects of the neurosteroid allopregnanolone: interactions with GABA(A) receptors Eur J Pharmacol 325 1-7